Global private investment firm, Bridgewest Group, recognized for developing innovative companies in life sciences, software, ...
HERZLIYA, Israel and CALGARY, AB, Jan. 29, 2025 /PRNewswire/ -- Innocan Pharma Corporation (CSE: INNO) (FSE: IP4) (OTCQB: INNPF) ("Innocan" or the "Company"), a pioneer in the pharmaceutical ...
May River Capital, a Chicago-based lower middle-market private equity firm, today announced the merger of its portfolio companies, Advanced Material Processing ('AMP') and Automated Handling Solutions ...
The company has secured $410m in an oversubscribed Series A funding round, co-led by Forbion and General Atlantic, with contributions from investors such as RA Capital Management, OrbiMed, Logos ...
The company – led by Mark McKenna ... It was led by venture capital firm ARCH Venture Partners, with other prominent biotech investors participating, including OrbiMed, Fairmount, Fidelity ...
These names in the biotech sector are seeing a substantial increase in search activity today, as determined by InvestingChannel. They ...
Avenue Therapeutics is a specialty pharmaceutical company focused on the development and commercialization of therapies for the treatment of neurologic diseases. It is currently developing three ...
3don MSN
Kassa and others said Big Pharma continues to invest even as private equity funds have pulled back. He noted ...
Dublin, Jan. 27, 2025 (GLOBE NEWSWIRE) -- The "International Directory of Biotechnology Companies 2025" has been added to ResearchAndMarkets.com's offering. The International Directory of ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback